% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • eiretekk eiretekk Nov 7, 2012 8:57 PM Flag

    Lame Downgrade

    Agreed - this is a development stage biotech. Anyone knows ratings should be based on pipeline prospects, not p/e. It may be that those prospects are getting so close that other forces have decided it's time to accumulate and The Street is not exactly what could be termed a reputable player in this regard. Buy on the dips here. That's my plan.

49.61+2.56(+5.44%)3:59 PMEDT